EP3213750
Samsetning tveggja veirueyðandi lyfja til að meðhöndla lifrarbólgu C
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.3.2014EP published:
12.8.2020EP application number:
17165207.6
EP translation filed:
23.9.2020Grant published:
15.10.2020EPO information:
European Patent Register
Max expiry date:
13.3.2034Expiry date:
13.3.2027Next due date:
31.3.2027
Title:
COMBINATION OF TWO ANTIVIRALS FOR TREATING HEPATITIS C
Timeline
Today
14.3.2014EP application
12.8.2020EP Publication
23.9.2020Translation submitted
15.10.2020Registration published
13.3.2027Expires
Owner
Name:
AbbVie Inc.Address:
1 North Waukegan Road, North Chicago, IL 60064, US
Inventor
Name:
BERNSTEIN, Barry M.Address:
Mequon, WI 53092, US
Name:
DUTTA, SandeepAddress:
Lincolnshire, IL 60069, US
Name:
LIU, WeiAddress:
Mundelein, IL 60060, US
Name:
PODSADECKI, Thomas J.Address:
Northbrook, IL 60062, US
Name:
CAMPBELL, Andrew L.Address:
Lake Forest, IL 60045, US
Name:
MENON, Rajeev M.Address:
Buffalo Grove, IL 60089, US
Name:
LIN, Chih-WeiAddress:
Vernon Hills, IL 60061, US
Name:
WANG, TianliAddress:
Lincolnshire, IL 60069-3220, US
Name:
AWNI, Walid M.Address:
Green Oaks, IL 60048, US
Name:
MENSING, SvenAddress:
68305 Mannheim, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201361783376 PDate:
14.3.2013Country:
US
Classification
Categories:
A61K 31/454, A61K 31/498, A61P 31/12
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 10.2.2021
Expires: 13.3.2022
Payer: Örn Þór slf.
Number: 9
Paid: 15.2.2022
Expires: 13.3.2023
Payer: Árnason Faktor ehf.
Number: 10
Paid: 12.2.2023
Expires: 13.3.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 12.2.2023
Expires: 13.3.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 12.2.2024
Expires: 13.3.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 29.1.2025
Expires: 13.3.2026
Payer: Árnason Faktor ehf.
Number: 13
Paid: 5.3.2026
Expires: 13.3.2027
Payer: Árnason Faktor ehf.